Home > Newsletters > Drug Industry Daily > Woodcock: CDER to Publish Guidance on Postmarket Tracked Safety Issues
Drug Industry Daily
Nov. 2, 2011 | Vol. 10 No. 215
Woodcock: CDER to Publish Guidance on Postmarket Tracked Safety Issues
CDER plans to issue guidance on how it assesses the relative urgency of postmarket tracked safety issues (TSIs) for drugs so it can better direct resources toward those that pose the greatest risk, CDER Director Janet Woodcock says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.